Pure Bioscience, Inc. (PURE) stock
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
Pure Bioscience cash
Cash and short-term investments held at the end of each period.
Pure Bioscience's cash was $569.00K at Jul 31, 2026. For fiscal 2026 it was $569.00K, up 70.4% from the year before. Over ten years it grew -19.8% a year on average. The highest annual figure on record is $5.19M in fiscal 2016.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $569.00K | +70.4% |
| FY2025 | Jul 31, 2025 | $334.00K | -4.3% |
| FY2024 | Jul 31, 2024 | $349.00K | -68.1% |
| FY2023 | Jul 31, 2023 | $1.10M | -67.7% |
| FY2022 | Jul 31, 2022 | $3.39M | +41.9% |
| FY2021 | Jul 31, 2021 | $2.39M | -37.7% |
| FY2020 | Jul 31, 2020 | $3.84M | +864.6% |
| FY2019 | Jul 31, 2019 | $398.00K | -53.2% |
| FY2018 | Jul 31, 2018 | $851.00K | -50.4% |
| FY2017 | Jul 31, 2017 | $1.72M | -67.0% |
| FY2016 | Jul 31, 2016 | $5.19M | +293.2% |
| FY2015 | Jul 31, 2015 | $1.32M | +1436.0% |
| FY2014 | Jul 31, 2014 | $86.00K | 0.0% |
| FY2013 | Jul 31, 2013 | $86.00K | -90.2% |
| FY2012 | Jul 31, 2012 | $877.00K | -51.1% |
| FY2011 | Jul 31, 2011 | $1.79M | -18.2% |
| FY2010 | Jul 31, 2010 | $2.19M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $569.00K | +70.4% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $983.00K | +82.0% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $198.00K | -2.0% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $434.00K | +25.4% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $334.00K | -4.3% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $540.00K | +22.2% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $202.00K | -63.7% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $346.00K | -76.0% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $349.00K | -68.1% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $442.00K | -43.4% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $557.00K | -62.5% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $1.44M | -41.3% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $1.10M | -67.7% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $781.00K | +52.8% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $1.49M | +31.3% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $2.45M | +39.3% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $3.39M | +41.9% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $511.00K | -81.9% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $1.13M | -61.4% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $1.76M | -49.2% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $2.39M | -37.7% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $2.82M | +39.4% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $2.93M | +1089.8% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $3.47M | +283.4% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $3.84M | +864.6% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $2.02M | +494.7% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $246.00K | -26.6% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $904.00K | +16.5% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $398.00K | -53.2% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $340.00K | -66.6% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $335.00K | -84.3% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $776.00K | -76.5% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $851.00K | -50.4% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $1.02M | -62.5% |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $2.13M | -45.3% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $3.30M | -18.7% |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $1.72M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $2.71M | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $3.89M | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | $4.06M | – |
See a number that looks wrong?